Related Experiment Video

Updated: Jul 20, 2025

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model
07:20

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model

Published on: February 10, 2023

1.3K

Preventing Deadly Complications of Cardiac Sarcoidosis

Gurinder K Sunner1, Jude Elsaygh1, Kunal Mehta2

  • 1Internal Medicine, New York Presbyterian Brooklyn Methodist Hospital, New York City, USA.

Cureus
|August 1, 2023
PubMed

Insights

Cardiac sarcoidosis, a rare heart complication, can cause serious issues. Early placement of a dual chamber implantable cardiac defibrillator (ICD) can prevent life-threatening conduction problems.

Area of Science:

  • Cardiology
  • Immunology

Background:

  • Cardiac sarcoidosis is a rare but serious complication of pulmonary sarcoidosis.
  • It involves granulomatous inflammation of the heart muscle, leading to infiltrative cardiomyopathy.

Observation:

  • Cardiac sarcoidosis can cause significant complications including conduction abnormalities, ventricular arrhythmias, heart failure, and sudden cardiac death.
  • Conduction abnormalities in cardiac sarcoidosis carry an adverse prognosis.

Findings:

  • Dual chamber implantable cardiac defibrillator (ICD) therapy is effective in reducing mortality and morbidity in patients with cardiac sarcoidosis.
  • Early ICD placement can prevent further immune-driven fibrotic conduction complications.

Implications:

  • This case highlights the importance of early ICD intervention for managing cardiac sarcoidosis.
  • Timely defibrillator implantation can improve patient outcomes and prevent sudden cardiac death.

Keywords:
atrioventricular blockscardiac sarcoidosisconduction abnormalitieselectrophysiology studiesicd therapyventricular tachycardia

More Related Videos

Mouse Heterotopic Cervical Cardiac Transplantation Utilizing Vascular Cuffs08:44

Mouse Heterotopic Cervical Cardiac Transplantation Utilizing Vascular Cuffs

Published on: June 23, 2022

3.1K
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.3K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
16
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
13
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
9
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
16